Immediate improvements in chronic central post-stroke pain, sensory dysfunction, spasticity, and brain fog after perispinal etanercept treatment by Dr. Tobinick. Filmed on November 19, 2021, at the Institute of Neurological Recovery in Boca Raton, Florida, more than 2 years after stroke.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Reduced central post-stroke pain, improved vision and improved sensation after multiple strokes following treatment by Edward Tobinick, M.D. Treatment performed and filmed on October 27, 2021 at the Institute of Neurological Recovery in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvements in walking and cognition minutes after perispinal etanercept treatment by Edward Tobinick, M.D., at the Institute of Neurological Recovery in Boca Raton, Florida. Treatment performed and filmed on October 5, 2021.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Perispinal etanercept treatment by Edward Tobinick M.D., at the Institute of Neurological Recovery in Boca Raton, Florida. Treatment filmed on October 11, 2021, 11 months after acute COVID-19 infection.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvement in fine motor (hand) function, pain, and sensation 2 years after stroke. Perispinal etanercept treatment by Dr. Tobinick at the Institute of Neurological Recovery® in Boca Raton, Florida, on July 21, 2021.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0